Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Trade-Ideas LLC identified

Aetna

(

AET

) as a new lifetime high candidate. In addition to specific proprietary factors, Trade-Ideas identified Aetna as such a stock due to the following factors:

  • AET has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $183.1 million.
  • AET has traded 2.0 million shares today.
  • AET is trading at a new lifetime high.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in AET with the Ticky from Trade-Ideas. See the FREE profile for AET NOW at Trade-Ideas

More details on AET:

Aetna Inc. operates as a diversified health care benefits company in the United States. The company operates in three segments: Health Care, Group Insurance, and Large Case Pensions. The stock currently has a dividend yield of 1.2%. AET has a PE ratio of 14.0. Currently there are 11 analysts that rate Aetna a buy, no analysts rate it a sell, and 6 rate it a hold.

TST Recommends

The average volume for Aetna has been 3.0 million shares per day over the past 30 days. Aetna has a market cap of $25.3 billion and is part of the health care sector and health services industry. The stock has a beta of 0.84 and a short float of 1.8% with 2.05 days to cover. Shares are up 48.1% year to date as of the close of trading on Tuesday.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

TheStreetRatings.com

Analysis:

TheStreet Quant Ratings

rates Aetna as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, attractive valuation levels, good cash flow from operations and increase in net income. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity.

Highlights from the ratings report include:

  • The revenue growth greatly exceeded the industry average of 9.8%. Since the same quarter one year prior, revenues rose by 46.2%. This growth in revenue does not appear to have trickled down to the company's bottom line, displayed by a decline in earnings per share.
  • Compared to its closing price of one year ago, AET's share price has jumped by 60.28%, exceeding the performance of the broader market during that same time frame. Regarding the stock's future course, although almost any stock can fall in a broad market decline, AET should continue to move higher despite the fact that it has already enjoyed a very nice gain in the past year.
  • Net operating cash flow has significantly increased by 540.61% to $1,071.10 million when compared to the same quarter last year. In addition, AETNA INC has also vastly surpassed the industry average cash flow growth rate of 328.69%.
  • The net income growth from the same quarter one year ago has exceeded that of the Health Care Providers & Services industry average, but is less than that of the S&P 500. The net income increased by 3.9% when compared to the same quarter one year prior, going from $499.20 million to $518.60 million.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

null